scholarly journals Pharmacoenhancement of Low Crizotinib Plasma Concentrations in Patients with Anaplastic Lymphoma Kinase‐Positive Non‐Small Cell Lung Cancer using the CYP3A Inhibitor Cobicistat

2020 ◽  
Author(s):  
Nicolas Hohmann ◽  
Farastuk Bozorgmehr ◽  
Petros Christopoulos ◽  
Gerd Mikus ◽  
Antje Blank ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Anaplastic Lymphoma Kinase ◽  
Plasma Concentrations ◽  
Small Cell ◽  
Small Cell Lung ◽  
Anaplastic Lymphoma ◽  
Cyp3a Inhibitor

Ceritinib compassionate use for patients with crizotinib-refractory, anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer

2018 ◽  
Vol 14 (4) ◽  
pp. 353-361 ◽  
Author(s):  
Giulio Metro ◽  
Antonio Passaro ◽  
Giuseppe Lo Russo ◽  
Laura Bonanno ◽  
Raffaele Giusti ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Anaplastic Lymphoma Kinase ◽  
Small Cell ◽  
Compassionate Use ◽  
Small Cell Lung ◽  
Anaplastic Lymphoma

scholarly journals Efficacy and safety of crizotinib in patients with anaplastic lymphoma kinase-positive advanced-stage non-small-cell lung cancer

2018 ◽  
Vol Volume 10 ◽  
pp. 6555-6561 ◽  
Author(s):  
Ahmed Mohieldin ◽  
Ayman Rasmy ◽  
Mohamed Ashour ◽  
Muath Al-Nassar ◽  
Rola H Ali ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Anaplastic Lymphoma Kinase ◽  
Small Cell ◽  
Advanced Stage ◽  
Efficacy And Safety ◽  
Small Cell Lung ◽  
Anaplastic Lymphoma
Sign in / Sign up

Export Citation Format

Share Document